This is a Phase 2, two-stage, adaptive, 1:1 randomized, double-blind, vehicle-controlled clinical study evaluating the efficacy, safety, and tolerability of GX…

Eczema Atopic DermatitisEczemaAtopic Dermatitis

~Estimated

~$10 – $8,750

Turn TherapeuticsNCT07355075

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Atopic DermatitisAtopicDermatitis+5 more

~Estimated

~$10 – $8,750

Apollo Therapeutics LtdNCT07599813